![Kein Bild](https://static.cymitquimica.com/public/img/logo-cymit-gray.png)
![Targetmol Targetmol logo](https://static.cymitquimica.com/public/img/partners/targetmol.png)
CHMFL-FLT3-122
CAS: 1839150-56-9
Ref. TM-T27011
1mg | Ausgelaufen | ||
5mg | Ausgelaufen | ||
10mg | Ausgelaufen | ||
25mg | Ausgelaufen | ||
50mg | Ausgelaufen | ||
100mg | Ausgelaufen | ||
500mg | Ausgelaufen |
Produktinformation
- CHMFLFLT3122, CHMFL FLT3 122
CHMFL-FLT3-122 is a potent and orally available FLT3 kinase inhibitor used to treat FLT3-ITD positive acute myeloid leukemia. CHMFL-FLT3-122 significantly suppressed the tumor growth in MV4-11 cell inoculated xenograft model (50 mg/kg) without exhibiting obvious toxicity in vivo.